143 related articles for article (PubMed ID: 1525956)
1. Synthesis and antitumor activities of mitomycin C (1----3)-beta-D-glucan conjugate.
Nagai K; Tanaka J; Kiho T; Ukai S
Chem Pharm Bull (Tokyo); 1992 Apr; 40(4):986-9. PubMed ID: 1525956
[TBL] [Abstract][Full Text] [Related]
2. Preparation and antitumor activities of mitomycin C beta-(1-->6)-branched (1-->3)-beta-D-glucan conjugate.
Usui S; Murashima K; Sakai M; Kiho T; Ukai S
Biol Pharm Bull; 1994 Sep; 17(9):1165-70. PubMed ID: 7841935
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of polymorphonuclear leukocytes activated by a beta-1,3-D-glucan.
Kasai S; Fujimoto S; Nitta K; Baba H; Kunimoto T
J Pharmacobiodyn; 1991 Sep; 14(9):519-25. PubMed ID: 1779406
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of mitomycin C-dextran conjugate against various murine tumors.
Hashida M; Kato A; Kojima T; Muranishi S; Sezaki H; Tanigawa N; Satomura K; Hikasa Y
Gan; 1981 Apr; 72(2):226-34. PubMed ID: 6169584
[TBL] [Abstract][Full Text] [Related]
5. [Synthesis and antitumor activities of conjugates of mitomycin C-polysaccharide from Tremella fuciformis].
Ukai S; Kiriki H; Nagai K; Kiho T
Yakugaku Zasshi; 1992 Sep; 112(9):663-8. PubMed ID: 1469614
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic characteristics and antitumor activity of the N-succinyl-chitosan-mitomycin C conjugate and the carboxymethyl-chitin-mitomycin C conjugate.
Song Y; Onishi H; Nagai T
Biol Pharm Bull; 1993 Jan; 16(1):48-54. PubMed ID: 8369752
[TBL] [Abstract][Full Text] [Related]
7. Induction of tumoricidal activity of polymorphonuclear leukocytes by a linear beta-1,3-D-glucan and other immunomodulators in murine cells.
Morikawa K; Takeda R; Yamazaki M; Mizuno D
Cancer Res; 1985 Apr; 45(4):1496-501. PubMed ID: 3156669
[TBL] [Abstract][Full Text] [Related]
8. Hydrogen peroxide as a tumoricidal mediator of murine polymorphonuclear leukocytes induced by a linear beta-1,3-D-glucan and some other immunomodulators.
Morikawa K; Kamegaya S; Yamazaki M; Mizuno D
Cancer Res; 1985 Aug; 45(8):3482-6. PubMed ID: 2990672
[TBL] [Abstract][Full Text] [Related]
9. In vivo properties of the conjugates of mitomycin C with estradiol benzoate and estradiol: pharmacokinetics and antitumor characteristics against P388 leukemia and sarcoma 180.
Ishiki N; Onishi H; Machida Y
Biol Pharm Bull; 1998 Nov; 21(11):1180-6. PubMed ID: 9853409
[TBL] [Abstract][Full Text] [Related]
10. In vivo drug release and antitumor characteristics of water-soluble conjugates of mitomycin C with glycol-chitosan and N-succinyl-chitosan.
Sato M; Onishi H; Takahara J; Machida Y; Nagai T
Biol Pharm Bull; 1996 Sep; 19(9):1170-7. PubMed ID: 8889036
[TBL] [Abstract][Full Text] [Related]
11. Dependence on chain length of antitumor activity of (1 leads to 3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes, IFO 13140, and its acid-degraded products.
Sasaki T; Abiko N; Sugino Y; Nitta K
Cancer Res; 1978 Feb; 38(2):379-83. PubMed ID: 620409
[TBL] [Abstract][Full Text] [Related]
12. Polysaccharides in fungi. XXXVII. Immunomodulating activities of carboxymethylated derivatives of linear (1-->3)-alpha-D-glucans extracted from the fruiting bodies of Agrocybe cylindracea and Amanita muscaria.
Yoshida I; Kiho T; Usui S; Sakushima M; Ukai S
Biol Pharm Bull; 1996 Jan; 19(1):114-21. PubMed ID: 8820922
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of 7-N-[[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]]-mitomycin C.
Morimoto M; Ashizawa T; Ohno H; Azuma M; Kobayashi E; Okabe M; Gomi K; Kono M; Saitoh Y; Kanda Y
Cancer Res; 1991 Jan; 51(1):110-5. PubMed ID: 1988076
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of tetrahydro-2-furanyl- and tetrahydro-2-pyranyl-glucans obtained by chemical modification of (1 leads to 3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes IFO 13140 and its lower molecular weight glucans.
Sasaki T; Abiko N; Uchida H; Tanaka M; Nitta K; Yoshioka Y; Nomura H
Cancer Treat Rep; 1983 Mar; 67(3):275-80. PubMed ID: 6831473
[TBL] [Abstract][Full Text] [Related]
15. Activation of the alternative pathway of complement by an antitumor (1----3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes IFO 13140, and its lower molecular weight and carboxymethylated derivatives.
Honda S; Sugino H; Asano T; Kakinuma A
Immunopharmacology; 1986 Feb; 11(1):29-37. PubMed ID: 3957648
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity and toxicity in animals of N-7[2-(4-nitrophenyldithio) ethyl] mitomycin C (BMY-25067).
Bradner WT; Rose WC; Schurig JE; Florczyk AP
Invest New Drugs; 1990; 8 Suppl 1():S1-7. PubMed ID: 2380013
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of a highly branched (1----3)-beta-D-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395.
Ohno N; Kurachi K; Yadomae T
J Pharmacobiodyn; 1987 Sep; 10(9):478-86. PubMed ID: 3437391
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activities of conjugates of mitomycin C with estradiol benzoate and estradiol via glutaric acid in suspension dosage form.
Ishiki N; Onishi H; Machida Y
Biol Pharm Bull; 2002 Oct; 25(10):1373-7. PubMed ID: 12392099
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of antitumor activity and immunomodulatory effect of tetrahydro-2-furanyl and tetrahydro-2-pyranyl (1 leads to 3)-beta-D-glucans.
Uchida H; Sasaki T
J Pharmacobiodyn; 1983 Sep; 6(9):660-7. PubMed ID: 6655547
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of the antitumor activity of M-16 and M-18, major metabolites of a new mitomycin C derivative KW-2149, in mice.
Ashizawa T; Okamoto A; Okabe M; Kobayashi S; Arai H; Saito H; Kasai M; Gomi K
Anticancer Drugs; 1995 Dec; 6(6):763-70. PubMed ID: 8845489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
